Editorial: Cross-species transmission of viral infections. [PDF]
Guterres A.
europepmc +1 more source
Quantifying vaccine dissemination for uptake comparisons between vaccines. [PDF]
Dirks A, Do H, Ford M, Getz K.
europepmc +1 more source
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies. [PDF]
Singh G +13 more
europepmc +1 more source
Hospitalized children with influenza virus: a 17 year-long observational study including the 2009 H1N1 influenza pandemic and COVID-19 pandemic. [PDF]
Jalving HT +5 more
europepmc +1 more source
Evolutionary trajectory and co-infection dynamics of human influenza A(H1N1) virus (2000-2025): an integrated framework informed by expert-informed bibliometrics. [PDF]
Cao X +7 more
europepmc +1 more source
Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history. [PDF]
Ort JT +8 more
europepmc +1 more source
Increased burden of influenza A/H1N1pdm09 in older adults following the COVID-19 pandemic
Jong SPJd, Russell CA.
europepmc +1 more source
Pandemic (H1N1) 2009 influenza [PDF]
On 11 June 2009, the World Health Organization declared the first human influenza pandemic since 1968–1969. The responsible virus, pandemic (H1N1) 2009 influenza, is a novel triple-reassortant influenza A virus, incorporating avian, swine and human influenza genes.1 The virus is resistant to the anti-influenza medications, amantadine and rimantadine ...
A Dennis
exaly +6 more sources
Related searches:
Overview/reflections on the 2009 H1N1 pandemic
Microbes and Infection, 2011The Influenza A H1N1 2009 pandemic was a test of the global public health response. Strategies that worked included mass vaccine production and antivirals while quarantine and isolation proved futile. Among the lessons learned was the importance of severity in the definition of a pandemic.
Surinder, Pada, Paul A, Tambyah
openaire +2 more sources

